tiprankstipranks
Advertisement
Advertisement
Johnson & Johnson price target raised to $282 from $275 at Goldman Sachs
PremiumThe FlyJohnson & Johnson price target raised to $282 from $275 at Goldman Sachs
2d ago
Johnson & Johnson price target raised to $270 from $260 at JPMorgan
Premium
The Fly
Johnson & Johnson price target raised to $270 from $260 at JPMorgan
2d ago
Johnson & Johnson price target raised to $294 from $284 at Morgan Stanley
Premium
The Fly
Johnson & Johnson price target raised to $294 from $284 at Morgan Stanley
2d ago
Johnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand
PremiumThe FlyJohnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand
3d ago
Johnson & Johnson Stock (JNJ) Falls despite Q2 Beat, Higher Sales Forecast for 2026
Premium
Market News
Johnson & Johnson Stock (JNJ) Falls despite Q2 Beat, Higher Sales Forecast for 2026
3d ago
Johnson & Johnson says three of four business units accelerated through Q2
Premium
The Fly
Johnson & Johnson says three of four business units accelerated through Q2
3d ago
Johnson & Johnson says has strongest portfolio, pipeline in company’s history
PremiumThe FlyJohnson & Johnson says has strongest portfolio, pipeline in company’s history
3d ago
Options Volatility and Implied Earnings Moves Today, July 15, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, July 15, 2026
3d ago
Genmab reports Q2 net sales of Darzalex $4.207B
Premium
The Fly
Genmab reports Q2 net sales of Darzalex $4.207B
3d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100